E-Mail
The global battle against antibiotic resistance can only succeed if local contexts are taken into account. A tailored approach is needed in each country, says Heiman Wertheim of Radboud university medical center. There is no one-size-fits-all solution. This was the main finding of a study on antibiotic resistance in African and Asian countries funded by the British Wellcome Trust. Wertheim is the lead investigator of a large group of international researchers who recently published an article on this study in
The Lancet Global Health.
Antibiotics are powerful treatments for bacterial infections. They are indispensable for controlling infections such as pneumonia, meningitis, or blood poisoning (sepsis) caused by bacteria. But they are ineffective for treating viral infections, such as colds or flu, and do not work against infections with parasites, fungi or yeasts either.
E-Mail
IMAGE: Eleanor M. Walker, M.D., PAACT co-investigator, and director of Breast Radiation Oncology and medical director of Integrative Services at Henry Ford view more
Credit: Henry Ford Health System
DETROIT (March 11, 2021) - Henry Ford Cancer Institute is launching the Participatory Action for Access to Clinical Trials (PAACT) project to dramatically improve the representation of the African American community and other minorities in cancer clinical trials.
Supported by a $750,000 grant from Genentech, PAACT is a community-based research initiative in collaboration with the Detroit Community-Academic Urban Research Center (Detroit URC) that will address various barriers to trust and participation in clinical trials. Researchers and community partners will focus on clinical trials involving breast, colorectal, lung, and prostate cancers, which are more likely to result in death for African Americans when compared to other racial and ethnic groups. The project
Patients suffering from dry eye disease symptoms have a lower quality of life compared to those without symptoms, a new study reports. The findings showed that patients with the condition reported negative effects on visual function, their ability to carry out daily activities and their work productivity.
Findings of this study suggest that patients recovering from COVID-19-associated acute kidney injury require monitoring of kidney function following hospital discharge.